Company / Revenue
VitaNova Life Sciences Corp Revenue History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.7M
FY2024
5-year range
$38.0K / $2.7M
FY2020-FY2024
Trend
+366.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +366% YoY in FY2024, a notable deviation from the 3-year average annual change of +567%.
Based on SEC 10-K filings.
$3M in FY2024 with a 3-year CAGR of +181.0%.
Improved from $38,000 to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +181.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +181.0%, indicating consistent growth.
- In FY2024, revenue increased 366.5% year-over-year.
- Lowest revenue in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $2.7M | +366.5% |
| FY2023 | $570.7K | +1401.8% |
| FY2022 | $38.0K | -68.3% |
| FY2021 | $120.0K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026